Retinoid X receptor α controls innate inflammatory responses through the up-regulation of chemokine expression

Vanessa Núñez(Centro Nacional de Epidemiología), Daniel Alameda, Daniel Rico, Rubén Mota(Spanish National Centre for Cardiovascular Research), Pilar Gonzalo(Spanish National Centre for Cardiovascular Research), Marta Cedenilla, Thierry Fischer(Centro Nacional de Biotecnología), Lisardo Boscá(Instituto de Investigaciones Biomédicas Sols-Morreale), Christopher K. Glass(University of California San Diego), Alicia G. Arroyo(Spanish National Centre for Cardiovascular Research), Mercedes Ricote(Spanish National Centre for Cardiovascular Research)
Proceedings of the National Academy of Sciences
May 24, 2010
Cited by 131

Abstract

The retinoid X receptor alpha (RXRalpha) plays a central role in the regulation of many intracellular receptor signaling pathways and can mediate ligand-dependent transcription by forming homodimers or heterodimers with other nuclear receptors. Although several members of the nuclear hormone receptor superfamily have emerged as important regulators of macrophage gene expression, the existence in vivo of an RXR signaling pathway in macrophages has not been established. Here, we provide evidence that RXRalpha regulates the transcription of the chemokines Ccl6 and Ccl9 in macrophages independently of heterodimeric partners. Mice lacking RXRalpha in myeloid cells exhibit reduced levels of CCL6 and CCL9, impaired recruitment of leukocytes to sites of inflammation, and lower susceptibility to sepsis. These studies demonstrate that macrophage RXRalpha plays key roles in the regulation of innate immunity and represents a potential target for immunotherapy of sepsis.


Related Papers

No related papers found

Powered by citation graph analysis